Oxandrolone, a synthetic testosterone analog, is used for the treatment of several diseases associated with weight loss. Unfortunately, oxandrolone is abused by many athletes and bodybuilders due to its strong anabolic effect. We have developed and validated a highly sensitive and rapid on-line SPE-UHPLC-MS/MS method for the determination of oxandrolone and simultaneous identification of its major metabolite 17-epi-oxandrolone in urine matrices. Enrichment of the analytes via an integrated solid-phase extraction was achieved using an Acquity UPLC BEH C18 Column. Subsequently, the chromatographic separation of the on-line preconcentrated sample fraction was achieved using an Acquity HSS T3 C18 Column. For the structural identification of these analytes, a high-resolution mass spectrometer Synapt-G2Si coupled to the Acquity M-class nano-LC system with ionKey source was used. A highly sensitive determination of oxandrolone was achieved using a tandem quadrupole mass spectrometer XEVO TQD. The method was successfully validated in the linear range of oxandrolone from 81.63 pg·mL-1 (limit of quantification, LOQ) to 5000 pg·mL-1 in the human urine matrix. It was applied to the analysis of real urine samples obtained from a healthy volunteer after the oral administration of one dose (10 mg) of oxandrolone. Concentration vs. time dependence was tested in the time interval of 4 h-12 days (after oral administration) to demonstrate the ability of the method to detect the renal elimination of oxandrolone from the human body. Favorable performance parameters along with successful application indicate the usefulness of the proposed method for its routine use in antidoping control labs.

Biomedical Center Martin Jessenius Faculty of Medicine in Martin Comenius University in Bratislava 036 01 Martin Slovakia

Biomedical Research Center of the Slovak Academy of Sciences in Bratislava 84510 Bratislava Slovakia

Department of Analytical Chemistry Faculty of Science Charles University Hlavova 8 128 43 Prague 2 Czech Republic

Department of Chemistry Faculty of Natural Science Matej Bel University in Banska Bystrica 974 09 Banska Bystrica Slovakia

Department of Pharmaceutical Analysis and Nuclear Pharmacy Faculty of Pharmacy Comenius University in Bratislava Odbojarov 10 832 32 Bratislava Slovakia

Department of Pharmacology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava 036 01 Martin Slovakia

Institute of Neuroimmunology Slovak Academy of Sciences Dubravska cesta 9 84510 Bratislava Slovakia

Toxicological and Antidoping Center Faculty of Pharmacy Comenius University in Bratislava Odbojarov 10 832 32 Bratislava Slovakia

Zobrazit více v PubMed

Pappo R., Jung C.J. 2-oxasteroids: A new class of biologically active compounds. Tetrahedron Lett. 1962;3:365–371. doi: 10.1016/S0040-4039(00)70883-5. DOI

Orr R., Fiatarone Singh M. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: Review of efficacy and safety. Drugs. 2004;64:725–750. doi: 10.2165/00003495-200464070-00004. PubMed DOI

Rojas Y., Finnerty C.C., Radhakrishnan R.S., Herndon D.N. Burns: An update on current pharmacotherapy. Expert Opin. Pharmacother. 2012;13:2485–2494. doi: 10.1517/14656566.2012.738195. PubMed DOI PMC

Garg A., Garg S., She R.W. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation. Burns. 2011;37:1150–1153. doi: 10.1016/j.burns.2011.06.007. PubMed DOI

Mendenhall C.L., Moritz T.E., Roselle G.A., Morgan T.R., Nemchausky B.A., Tamburro C.H., Schiff E.R., McClain C.J., Marsano L.S., Allen J.I., et al. The VA Cooperative Study Group #275. Protein energy malnutrition in severe alcoholic hepatitis: Diagnosis and response to treatment. J. Parenter. Enter. Nutr. 1995;19:258–265. PubMed

Mendenhall C.L., Moritz T.E., Roselle G.A., Morgan T.R., Nemchausky B.A., Tamburro C.H., Schiff E.R., McClain C.J., Marsano L.S., Allen J.I., et al. The VA Cooperative Study Group #275. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17:564–576. PubMed

Bonkovsky H.L., Singh R.H., Jafri I.H., Fiellin D.A., Smith G.S., Simon D., Cotsonis G.A., Slaker D.P. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am. J. Gastroenterol. 1991;86:1209–1218. PubMed

Fox-Wheeler S., Heller L., Salata C.M., Kaufman F., Loro M.L., Gilsanz V., Haight M., Umman G.C., Barton N., Church J.A. Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients. Pediatrics. 1999;104:e73. doi: 10.1542/peds.104.6.e73. PubMed DOI

Beaston-Blaakman A., Shepard D.S., Stone N., Shevitz A.H. Cost-effectiveness of clinical interventions for AIDS wasting. AIDS Care. 2007;19:996–1001. doi: 10.1080/09540120701335238. PubMed DOI

Miller J.T., Btaiche I.F. Oxandrolone in pediatric patients with severe thermal burn injury. Ann. Pharmacother. 2008;42:1310–1315. doi: 10.1345/aph.1L162. PubMed DOI

Demling R.H., DeSanti L. Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid. Burns. 2003;29:793–797. doi: 10.1016/j.burns.2003.08.003. PubMed DOI

Al-Tarrah K., Moiemen N., Lord J.M. The influence of sex steroid hormones on the response to trauma and burn injury. Burns Trauma. 2017;5:29. doi: 10.1186/s41038-017-0093-9. PubMed DOI PMC

Sheanon N.M., Backeljauw P.F. Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: A meta-analysis. Int. J. Pediatr. Endocrinol. 2015;2015:18. doi: 10.1186/s13633-015-0013-3. PubMed DOI PMC

Davis S.M., Cox-Martin M., Bardsley M.Z., Kowal K., Zeitler P.S., Ross J.L. Effects of Oxandrolone on Cardiometabolic Health in Boys with Klinefelter Syndrome: A Randomized Controlled Trial. J. Clin. Endocrinol. Metab. 2017;102:176–184. doi: 10.1210/jc.2016-2904. PubMed DOI PMC

Davis S.M., Lahlou N., Cox-Martin M., Kowal K., Zeitler P.S., Ross J.L. Oxandrolone Treatment Results in an Increased Risk of Gonadarche in Prepubertal Boys With Klinefelter Syndrome. J. Clin. Endocrinol. Metab. 2018;103:3449–3455. doi: 10.1210/jc.2018-00682. PubMed DOI PMC

Kuhn C.M. Anabolic steroids. Recent Prog. Horm. Res. 2002;57:411–434. doi: 10.1210/rp.57.1.411. PubMed DOI

Demling R.H. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns. 1999;25:215–221. doi: 10.1016/S0305-4179(98)00159-4. PubMed DOI

Ip E.J., Barnett M.J., Tenerowicz M.J., Kim J.A., Wei H., Perry P.J. Women and anabolic steroids: An analysis of a dozen users. Clin. J. Sport Med. 2010;20:475–481. doi: 10.1097/JSM.0b013e3181fb5370. PubMed DOI

La Vignera S., Condorelli R.A., Cannarella R., Duca Y., Calogero A.E. Sport, doping and female fertility. Reprod. Biol. Endocrinol. 2018;16:108. doi: 10.1186/s12958-018-0437-8. PubMed DOI PMC

Schänzer W., Donike M. Metabolism of anabolic steroids in man: Synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal. Chim. Acta. 1993;275:23–48. doi: 10.1016/0003-2670(93)80274-O. DOI

Schanzer W. Metabolism of anabolic androgenic steroids. Clin. Chem. 1996;42:1001–1020. doi: 10.1093/clinchem/42.7.1001. PubMed DOI

Masse R., Bi H.G., Ayotte C., Dugal R. Studies on anabolic steroids. II--Gas chromatographic/mass spectrometric characterization of oxandrolone urinary metabolites in man. Biomed. Environ. Mass Spectrom. 1989;18:429–438. doi: 10.1002/bms.1200180612. PubMed DOI

Ayotte C., Goudreault D., Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J. Chromatogr. B. 1996;687:3–25. doi: 10.1016/S0378-4347(96)00032-1. PubMed DOI

Chung B.C., Choo H.Y., Kim T.W., Eom K.D., Kwon O.S., Suh J., Yang J., Park J. Analysis of anabolic steroids using GC/MS with selected ion monitoring. J. Anal. Toxicol. 1990;14:91–95. doi: 10.1093/jat/14.2.91. PubMed DOI

Van Eenoo P., Van Gansbeke W., De Brabanter N., Deventer K., Delbeke F.T. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. J. Chromatogr. A. 2011;1218:3306–3316. doi: 10.1016/j.chroma.2010.09.082. PubMed DOI

Revelsky A.I., Samoshkin A.S., Virus E.D., Rodchenkov G.M., Revelsky I.A. High sensitive analysis of steroids in doping control using gas chromatography/time-of-flight mass-spectrometry. Drug Test. Anal. 2011;3:263–267. doi: 10.1002/dta.221. PubMed DOI

Pozo O.J., Deventer K., Van Eenoo P., Delbeke F.T. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry. Anal. Chem. 2008;80:1709–1720. doi: 10.1021/ac7020757. PubMed DOI

Leinonen A., Kuuranne T., Kostiainen R. Liquid chromatography/mass spectrometry in anabolic steroid analysis—Optimization and comparison of three ionization techniques: Electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. J. Mass Spectrom. 2002;37:693–698. doi: 10.1002/jms.328. PubMed DOI

Leinonen A., Kuuranne T., Kotiaho T., Kostiainen R. Screening of free 17-alkyl-substituted anabolic steroids in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids. 2004;69:101–109. doi: 10.1016/j.steroids.2003.10.007. PubMed DOI

Virus E.D., Sobolevsky T.G., Rodchenkov G.M. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control. J. Mass Spectrom. 2008;43:949–957. doi: 10.1002/jms.1447. PubMed DOI

Viryus E.D., Sobolevskii T.G., Rodchenkov G.M. Detection of oxandrolone and its metabolite in urine by high-performance liquid chromatography-high-resolution mass spectrometry with atmospheric pressure chemical ionization and orbitrap detection after ceasing drug administration. J. Anal. Chem. 2009;64:31–35. doi: 10.1134/S1061934809010079. DOI

Guddat S., Fussholler G., Beuck S., Thomas A., Geyer H., Reydevik A., Bondesson U., Hedeland M., Lagojda A., Schänzer W., et al. Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing. Anal. Bioanal. Chem. 2013;405:8285–8294. doi: 10.1007/s00216-013-7218-1. PubMed DOI

Rzeppa S., Viet L. Analysis of sulfate metabolites of the doping agents oxandrolone and danazol using high performance liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B. 2016;1029–1030:1–9. doi: 10.1016/j.jchromb.2016.06.028. PubMed DOI

U.S. Department of Health and Human Services Food and Drug Administration Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry. [(accessed on 12 December 2020)];2015 Available online: https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf.

Kootstra P.R., Zoontjes P.W., van Tricht E.F., Sterk S.S. Multi-residue screening of a minimum package of anabolic steroids in urine with GC-MS. Anal. Chim. Acta. 2007;586:82–92. doi: 10.1016/j.aca.2006.11.056. PubMed DOI

WADA Minimum Required Performance Levels for Detection and Identification of Non-Threshold Sunstances. [(accessed on 4 January 2021)];2014 Available online: https://www.wada-ama.org/sites/default/files/resources/files/WADA-TD2014MRPL-v1-Minimum-Required-Performance-Levels-EN.pdf.

WADA Identification Criteria for Qualitative Assay Incorporating Column Chromatography and Mass Spectrometry. [(accessed on 4 January 2021)];2010 Available online: https://www.wada-ama.org/sites/default/files/resources/files/WADA_TD2010IDCRv1.0_Identification%20Criteria%20for%20Qualitative%20Assays_May%2008%202010_EN.doc.pdf.

Tircova B., Bosakova Z., Kozlik P. Development of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia. Drug Test. Anal. 2019;11:355–360. doi: 10.1002/dta.2541. PubMed DOI